Dow Up0.11% Nasdaq Up0.50%

Codexis, Inc. (CDXS)

-NasdaqGS
2.54 Down 0.02(0.78%) Aug 29, 4:00PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
CDXSPVT1PVT2PVT3Industry
Market Cap:99.40MN/AN/AN/A155.47M
Employees:1259,93516,236124,349152.00
Qtrly Rev Growth (yoy):-0.06N/AN/AN/A0.18
Revenue (ttm): 27.11M4.02B12.17B112.46B18.90M
Gross Margin (ttm):-0.29N/AN/AN/A0.52
EBITDA (ttm):-22.24MN/AN/AN/A-10.00M
Operating Margin (ttm): -1.15N/AN/AN/A-1.53
Net Income (ttm):-33.93M97.70M1405.90M1373.10M1N/A
EPS (ttm):-0.99N/AN/AN/A-0.30
P/E (ttm):N/AN/AN/AN/A30.18
PEG (5 yr expected):-0.59N/AN/AN/AN/A
P/S (ttm):3.70N/AN/AN/A16.61
 
Pvt1 = Lonza Group AG
Pvt2 = Novozymes A/S
Pvt3 = Royal DSM N.V.
Industry = Biotechnology
1 = As of 2013  

Biotechnology Companies Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN139.380.00105.87B22.63
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB343.040.0181.01B42.67
Genzyme CorporationPrivate - View Profile
Merck Serono S.A.Private - View Profile
Gilead Sciences Inc.GILD107.560.00162.60B39.84
MedImmune, L.L.C.Private - View Profile
Life Technologies CorporationPrivate - View Profile
Teva Pharmaceutical Industries LimitedTEVA52.520.0144.84B32.44
Sandoz International GmbHPrivate - View Profile
 
View Biotechnology Industry Center

Generic Drugmakers Ranked by Sales 
CompanySymbolPriceChangeMarket CapP/E
Actavis plcACT226.980.0059.98BN/A
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL48.600.0118.18B30.36
Pfizer Inc.PFE29.390.00186.36B9.12
Johnson & JohnsonJNJ103.730.01292.55B19.84
GlaxoSmithKline plcGSK49.100.00117.94B13.96
SanofiSNY54.700.00143.54B28.08
Novartis AGNVS89.840.00217.97B22.92
Roche Holding AGRHHBY36.51-0.00248.08B20.32
AstraZeneca PLCAZN76.010.0296.00B46.60
 
View Biotechnology Industry Center

Drugmakers Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Abbott LaboratoriesABT42.24-0.0063.52B27.63
Bristol-Myers Squibb CompanyBMY50.650.0083.97B29.28
 
View Biotechnology Industry Center

 
News on Direct Competitors 
No Direct Competitor Comparision

Currency in USD.